2-Allyl-4-cyclohexyl-phenol | 314050-89-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Allyl-4-cyclohexyl-phenol
• 英文别名: 2-Allyl-4-cyclohexylphenol；4-cyclohexyl-2-prop-2-enylphenol
• CAS: 314050-89-0
• 化学式: C₁₅H₂₀O
• 分子量: 216.323
• InChiKey: LCJTYLDPAOAIAQ-UHFFFAOYSA-N

物化性质

• 沸点：
  340.2±21.0 °C(Predicted)
• 密度：
  1.013±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-Allyl-4-cyclohexyl-phenol 在 palladium on activated charcoal 氨 、 氢气 、 sodium methylate 、 potassium carbonate 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 5-[3-(3-(2-propyl-4-cyclohexylphenoxy)propoxy)phenyl]-2,4-oxazolidinedione
  参考文献：
  名称：

  Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists

  摘要：

  A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.

  DOI：

  10.1016/s0960-894x(03)00785-6
• 作为产物：
  描述：

  1-allyloxy-4-cyclohexyl-benzene 以 邻二氯苯 为溶剂， 生成 2-Allyl-4-cyclohexyl-phenol
  参考文献：
  名称：

  Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists

  摘要：

  A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.

  DOI：

  10.1016/s0960-894x(03)00785-6

文献信息

• Novel epoxide derivatives of allylarylphenols
  申请人：——

  公开号：US20020151731A1

  公开（公告）日：2002-10-17

  The present invention relates to novel epoxides having the formulas 1 where Y is a CO, CO 2 or SO 2 , AR is the same or different divalent unsubstituted or substituted aromatic, halogen-substituted aromatic or cyano-substituted aromatic hydrocarbon radical having from 6 to 20 carbon atoms, Z is a divalent hydrocarbon or ether radical having from 1 to 20 carbon atoms, including Y—Z—Y being CO, and R* is an alkyl, aryl, arylalkyl, alkoxy, aryloxy or arylalkoxy radical having from 0-20 carbon atoms. The epoxides of the present invention are useful in the formation of epoxy resins.

  本发明涉及具有以下公式的新环氧化合物：1其中Y是CO、CO2或SO2，AR是相同或不同的二价未取代或取代的芳香族、卤素取代的芳香族或氰基取代的芳香族碳氢化合物基团，其含有6至20个碳原子，Z是具有1至20个碳原子的二价碳氢化合物或醚基团，包括Y—Z—Y为CO，R*是具有0-20个碳原子的烷基、芳基、芳烷基、烷氧基、芳氧基或芳烷氧基。本发明的环氧化合物在形成环氧树脂时很有用。
• Bis(μ-oxo)–Dititanium(IV)–Chiral Binaphthyldisulfonate Complexes for Highly Enantioselective Intramolecular Hydroalkoxylation of Nonactivated Alkenes
  作者：Wen-Bin Xie、Zhi Li

  DOI：10.1021/acscatal.1c01146

  日期：2021.5.21

  A series of chiral 1,1′-binaphthyl-2,2′-disulfonic acids was designed, synthesized, and applied in a highly enantioselective Ti-catalyzed intramolecular hydroalkoxylation of nonactivated alkenes. The catalyst is probably a complex between two chiral binaphthyldisulfonate ligands and a bis(μ-oxo)–dititanium(IV) core structure. The sulfonamide groups of the ligands and water are necessary for the catalysis

  设计，合成了一系列手性的1,1'-联萘-2,2'-二磺酸，并将其应用于高度对映选择性的Ti催化的非活化烯烃分子内加氢烷氧基化反应。该催化剂可能是两个手性联萘二磺酸酯配体与双（μ-氧代）-二钛（IV）核心结构之间的复合物。配体和水的磺酰胺基对于催化是必需的，因为它们可以通过氢键稳定催化活性的配合物。在温和条件下，以高达99％以上的收率和高达97％对映体过量的形式获得了各种2-甲基香豆素。
• Arylthiazolidinedione derivatives
  申请人：Merck & Co., Inc.

  公开号：US20020037911A1

  公开（公告）日：2002-03-28

  Substituted 5-aryl-2,4-thiazolidinediones and oxazolidinediones are potent agonists of PPAR, and are therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR &agr; and/or &ggr; mediated diseases, disorders and conditions.

  取代5-芳基-2,4-噻唑烷二酮和噁唑烷二酮是PPAR的有效激动剂，因此在治疗、控制或预防糖尿病、高血糖、高脂血症（包括高胆固醇血症和高甘油三酯血症）、动脉粥样硬化、肥胖、血管再狭窄和其他PPARα和/或γ介导的疾病、疾病和情况中非常有用。
• ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES
  申请人：Merck & Co., Inc.

  公开号：EP1194147A1

  公开（公告）日：2002-04-10
• EP1194147A4
  申请人：——

  公开号：EP1194147A4

  公开（公告）日：2002-10-09